CD163(Antibody) Market size is estimated to be USD 200 Million in 2024 and is expected to reach USD 400 Million by 2033 at a CAGR of 8.5% from 2026 to 2033.
The global CD163 (Antibody) market was valued at approximately USD 2.6 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7.1% from 2023 to 2030. The increasing prevalence of chronic diseases, coupled with advancements in antibody therapies, is expected to drive the market growth. The demand for CD163 antibodies is anticipated to rise due to their role in various medical applications, including diagnostics and treatment of conditions like cancer and inflammatory diseases. Furthermore, the market is experiencing significant growth due to the development of new monoclonal antibodies and the expanding research activities across the biopharmaceutical industry. North America dominated the market in 2022, contributing over 35% of the overall revenue share, attributed to the presence of major pharmaceutical companies and extensive research funding in the region.
In terms of regional distribution, Europe and Asia Pacific are also expected to witness significant growth in the CD163 antibody market over the forecast period. Europe held a substantial market share in 2022, primarily driven by the increasing adoption of advanced therapeutic options in countries such as Germany and the UK. The Asia Pacific region, projected to witness the highest CAGR during the forecast period, is expected to benefit from a growing focus on immunology research, rising healthcare investments, and increasing adoption of personalized medicine in countries like China and India. The emerging markets present considerable opportunities for market players due to expanding healthcare infrastructure, government initiatives, and rising awareness regarding the benefits of targeted antibody therapies.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=738494&utm_source=Google site_G_April&utm_medium=235
Key Player I
Key Player II
Key Player III
Key Player IV
Key Player V
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=738494&utm_source=Google site_G_April&utm_medium=235
Growing demand for below applications around the world has had a direct impact on the growth of the Global CD163(Antibody) Market
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
Antibody Fragments (e.g., Fab, scFv)
Diagnostic Applications
Therapeutics
Research and Development
Companion Diagnostics
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Contract Research Organizations (CROs)
Diagnostics Laboratories
Immunohistochemistry (IHC)
Flow Cytometry
Enzyme-Linked Immunosorbent Assay (ELISA)
Western Blotting
Human-Derived
Animal-Derived
Recombinant Sources
Hybridoma Technology
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/cd163-antibody-market/
1. Introduction of the Global CD163(Antibody) Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global CD163(Antibody) Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global CD163(Antibody) Market, By Type
6. Global CD163(Antibody) Market, By Application
7. Global CD163(Antibody) Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global CD163(Antibody) Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/